Biomarkers in Parkinsonian Syndromes

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 16, 2013

Primary Completion Date

December 16, 2023

Study Completion Date

December 16, 2025

Conditions
Parkinsonian SyndromesParkinson's DiseaseMultiple System AtrophyProgressive Supranuclear Palsy
Interventions
OTHER

CSF, blood and urine sampling

PSP and MSA patients will receive CSF and blood sampling at two study visits (baseline and after 12 months).

OTHER

clinical measures of disease severity and progression

Questionnaires (quality of life, motricity scales, cognitive scales, depression scales, scale of sleep quality)

Trial Locations (3)

31000

NOT_YET_RECRUITING

CHU de Toulouse, Toulouse

33640

RECRUITING

CHU de Bordeaux, Pessac

87000

RECRUITING

CHU de Limoges, Limoges

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER